Non-invasive detection of EGFR mutations by cell-free loop-mediated isothermal amplification (CF-LAMP)

Targeting epidermal growth factor receptor (EGFR) through tyrosine kinase inhibitors (TKI) is a successful therapeutic strategy in non-small cell lung cancer. However, the response to TKI therapy depends on specific activating and acquired mutations in the tyrosine kinase domain of the EGFR gene. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Arjuna, Srividya, Venkataram, Rajesh, Dechamma, Pandyanda Nanjappa, Chakraborty, Gunimala, Babu, Nishith, D’Cruz, Audrey, Hosmane, Giridhar Belur, Chakraborty, Anirban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568567/
https://www.ncbi.nlm.nih.gov/pubmed/33067539
http://dx.doi.org/10.1038/s41598-020-74689-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568567/
https://www.ncbi.nlm.nih.gov/pubmed/33067539
http://dx.doi.org/10.1038/s41598-020-74689-3

Ejemplares similares